These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21797811)

  • 21. A placebo controlled trial of bupropion for smoking cessation in schizophrenia.
    George TP; Vessicchio JC; Termine A; Bregartner TA; Feingold A; Rounsaville BJ; Kosten TR
    Biol Psychiatry; 2002 Jul; 52(1):53-61. PubMed ID: 12079730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bupropion: risks and benefits.
    Ross S; Williams D
    Expert Opin Drug Saf; 2005 Nov; 4(6):995-1003. PubMed ID: 16255659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
    Dalsgareth OJ; Hansen NC; Søes-Petersen U; Evald T; Høegholm A; Barber J; Vestbo J
    Nicotine Tob Res; 2004 Feb; 6(1):55-61. PubMed ID: 14982688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience.
    Ferry L; Johnston JA
    Int J Clin Pract; 2003 Apr; 57(3):224-30. PubMed ID: 12723728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications.
    Perkins KA; Lerman C; Karelitz JL; Jao NC; Chengappa KN; Sparks GM
    Addiction; 2013 Nov; 108(11):1962-8. PubMed ID: 23773319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of sustained-release bupropion and placebo for smoking cessation.
    Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
    N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy of bupropion in the management of smoking cessation.
    Jorenby D
    Drugs; 2002; 62 Suppl 2():25-35. PubMed ID: 12109933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study.
    Dale LC; Ebbert JO; Schroeder DR; Croghan IT; Rasmussen DF; Trautman JA; Cox LS; Hurt RD
    Nicotine Tob Res; 2002 Aug; 4(3):267-74. PubMed ID: 12215235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.
    King DP; Paciga S; Pickering E; Benowitz NL; Bierut LJ; Conti DV; Kaprio J; Lerman C; Park PW
    Neuropsychopharmacology; 2012 Feb; 37(3):641-50. PubMed ID: 22048466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: a pilot study.
    Upadhyaya HP; Brady KT; Wang W
    J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):199-205. PubMed ID: 14726727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
    Meszaros ZS; Abdul-Malak Y; Dimmock JA; Wang D; Ajagbe TO; Batki SL
    J Clin Psychopharmacol; 2013 Apr; 33(2):243-7. PubMed ID: 23422399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.
    Tashkin D; Kanner R; Bailey W; Buist S; Anderson P; Nides M; Gonzales D; Dozier G; Patel MK; Jamerson B
    Lancet; 2001 May; 357(9268):1571-5. PubMed ID: 11377644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suitability of bupropion SR for nicotine-dependent smokers: problems in a practice setting.
    Kohlenberg BS; Antonuccio DO; Hayes SC; Gifford EV; Piasecki MP
    Psychother Psychosom; 2004; 73(4):252-4. PubMed ID: 15184720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.
    Evins AE; Deckersbach T; Cather C; Freudenreich O; Culhane MA; Henderson DC; Green MF; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychiatry; 2005 Sep; 66(9):1184-90. PubMed ID: 16187778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results.
    Haggsträm FM; Chatkin JM; Sussenbach-Vaz E; Cesari DH; Fam CF; Fritscher CC
    Pulm Pharmacol Ther; 2006; 19(3):205-9. PubMed ID: 16517193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of bupropion sustained-release on cigarette craving after smoking cessation.
    Durcan MJ; Deener G; White J; Johnston JA; Gonzales D; Niaura R; Rigotti N; Sachs DP
    Clin Ther; 2002 Apr; 24(4):540-51. PubMed ID: 12017399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bupropion SR for the treatment of smokeless tobacco use.
    Dale LC; Ebbert JO; Glover ED; Croghan IT; Schroeder DR; Severson HH; Hurt RD
    Drug Alcohol Depend; 2007 Sep; 90(1):56-63. PubMed ID: 17353101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2005 Nov; 183(1):1-12. PubMed ID: 16160876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.